Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 69

1.

Conditional expression of Parkinson's disease-related R1441C LRRK2 in midbrain dopaminergic neurons of mice causes nuclear abnormalities without neurodegeneration.

Tsika E, Kannan M, Foo CS, Dikeman D, Glauser L, Gellhaar S, Galter D, Knott GW, Dawson TM, Dawson VL, Moore DJ.

Neurobiol Dis. 2014 Aug 29;71C:345-358. doi: 10.1016/j.nbd.2014.08.027. [Epub ahead of print]

PMID:
25174890
[PubMed - as supplied by publisher]
2.

Behavioral Deficits and Striatal DA Signaling in LRRK2 p.G2019S Transgenic Rats: A Multimodal Investigation Including PET Neuroimaging.

Walker MD, Volta M, Cataldi S, Dinelle K, Beccano-Kelly D, Munsie L, Kornelsen R, Mah C, Chou P, Co K, Khinda J, Mroczek M, Bergeron S, Yu K, Cao LP, Funk N, Ott T, Galter D, Riess O, Biskup S, Milnerwood AJ, Stoessl AJ, Farrer MJ, Sossi V.

J Parkinsons Dis. 2014 Jan 1;4(3):483-98. doi: 10.3233/JPD-140344.

PMID:
25000966
[PubMed - in process]
3.

Comparison of three hypothermic target temperatures for the treatment of hypoxic ischemia: mRNA level responses of eight genes in the piglet brain.

Olson L, Faulkner S, Lundströmer K, Kerenyi A, Kelen D, Chandrasekaran M, Ådén U, Olson L, Golay X, Lagercrantz H, Robertson NJ, Galter D.

Transl Stroke Res. 2013 Apr;4(2):248-57. doi: 10.1007/s12975-012-0215-4. Epub 2012 Oct 14.

PMID:
24323276
[PubMed - indexed for MEDLINE]
4.

Modulation of the endoplasmic reticulum-mitochondria interface in Alzheimer's disease and related models.

Hedskog L, Pinho CM, Filadi R, Rönnbäck A, Hertwig L, Wiehager B, Larssen P, Gellhaar S, Sandebring A, Westerlund M, Graff C, Winblad B, Galter D, Behbahani H, Pizzo P, Glaser E, Ankarcrona M.

Proc Natl Acad Sci U S A. 2013 May 7;110(19):7916-21. doi: 10.1073/pnas.1300677110. Epub 2013 Apr 25.

PMID:
23620518
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

mRNA expression, splicing and editing in the embryonic and adult mouse cerebral cortex.

Dillman AA, Hauser DN, Gibbs JR, Nalls MA, McCoy MK, Rudenko IN, Galter D, Cookson MR.

Nat Neurosci. 2013 Apr;16(4):499-506. doi: 10.1038/nn.3332. Epub 2013 Feb 17.

PMID:
23416452
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Enhanced dendritogenesis and axogenesis in hippocampal neuroblasts of LRRK2 knockout mice.

Paus M, Kohl Z, Ben Abdallah NM, Galter D, Gillardon F, Winkler J.

Brain Res. 2013 Feb 25;1497:85-100. doi: 10.1016/j.brainres.2012.12.024. Epub 2012 Dec 25.

PMID:
23270607
[PubMed - indexed for MEDLINE]
7.

Large-scale replication and heterogeneity in Parkinson disease genetic loci.

Sharma M, Ioannidis JP, Aasly JO, Annesi G, Brice A, Van Broeckhoven C, Bertram L, Bozi M, Crosiers D, Clarke C, Facheris M, Farrer M, Garraux G, Gispert S, Auburger G, Vilariño-Güell C, Hadjigeorgiou GM, Hicks AA, Hattori N, Jeon B, Lesage S, Lill CM, Lin JJ, Lynch T, Lichtner P, Lang AE, Mok V, Jasinska-Myga B, Mellick GD, Morrison KE, Opala G, Pramstaller PP, Pichler I, Park SS, Quattrone A, Rogaeva E, Ross OA, Stefanis L, Stockton JD, Satake W, Silburn PA, Theuns J, Tan EK, Toda T, Tomiyama H, Uitti RJ, Wirdefeldt K, Wszolek Z, Xiromerisiou G, Yueh KC, Zhao Y, Gasser T, Maraganore D, Krüger R; GEO-PD Consortium.

Neurology. 2012 Aug 14;79(7):659-67. doi: 10.1212/WNL.0b013e318264e353. Epub 2012 Jul 11.

PMID:
22786590
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Association of a protective paraoxonase 1 (PON1) polymorphism in Parkinson's disease.

Belin AC, Ran C, Anvret A, Paddock S, Westerlund M, Håkansson A, Nissbrandt H, Söderkvist P, Dizdar N, Ahmadi A, Anvret M, Willows T, Sydow O, Galter D.

Neurosci Lett. 2012 Jul 26;522(1):30-5. doi: 10.1016/j.neulet.2012.06.007. Epub 2012 Jun 13.

PMID:
22704918
[PubMed - indexed for MEDLINE]
9.

Genetic Screening of the Mitochondrial Rho GTPases MIRO1 and MIRO2 in Parkinson's Disease.

Anvret A, Ran C, Westerlund M, Sydow O, Willows T, Olson L, Galter D, Belin AC.

Open Neurol J. 2012;6:1-5. doi: 10.2174/1874205X01206010001. Epub 2012 Apr 3.

PMID:
22496713
[PubMed]
Free PMC Article
10.

MAGI1 copy number variation in bipolar affective disorder and schizophrenia.

Karlsson R, Graae L, Lekman M, Wang D, Favis R, Axelsson T, Galter D, Belin AC, Paddock S.

Biol Psychiatry. 2012 May 15;71(10):922-30. doi: 10.1016/j.biopsych.2012.01.020. Epub 2012 Feb 28.

PMID:
22381734
[PubMed - indexed for MEDLINE]
11.

Neurodegenerative phenotypes in an A53T α-synuclein transgenic mouse model are independent of LRRK2.

Daher JP, Pletnikova O, Biskup S, Musso A, Gellhaar S, Galter D, Troncoso JC, Lee MK, Dawson TM, Dawson VL, Moore DJ.

Hum Mol Genet. 2012 Jun 1;21(11):2420-31. doi: 10.1093/hmg/dds057. Epub 2012 Feb 21.

PMID:
22357653
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

PDGF-BB modulates hematopoiesis and tumor angiogenesis by inducing erythropoietin production in stromal cells.

Xue Y, Lim S, Yang Y, Wang Z, Jensen LD, Hedlund EM, Andersson P, Sasahara M, Larsson O, Galter D, Cao R, Hosaka K, Cao Y.

Nat Med. 2011 Dec 4;18(1):100-10. doi: 10.1038/nm.2575.

PMID:
22138754
[PubMed - indexed for MEDLINE]
13.

Adh1 and Adh1/4 knockout mice as possible rodent models for presymptomatic Parkinson's disease.

Anvret A, Ran C, Westerlund M, Gellhaar S, Lindqvist E, Pernold K, Lundströmer K, Duester G, Felder MR, Galter D, Belin AC.

Behav Brain Res. 2012 Feb 1;227(1):252-7. doi: 10.1016/j.bbr.2011.10.040. Epub 2011 Nov 6.

PMID:
22079585
[PubMed - indexed for MEDLINE]
14.

Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study.

Ross OA, Soto-Ortolaza AI, Heckman MG, Aasly JO, Abahuni N, Annesi G, Bacon JA, Bardien S, Bozi M, Brice A, Brighina L, Van Broeckhoven C, Carr J, Chartier-Harlin MC, Dardiotis E, Dickson DW, Diehl NN, Elbaz A, Ferrarese C, Ferraris A, Fiske B, Gibson JM, Gibson R, Hadjigeorgiou GM, Hattori N, Ioannidis JP, Jasinska-Myga B, Jeon BS, Kim YJ, Klein C, Kruger R, Kyratzi E, Lesage S, Lin CH, Lynch T, Maraganore DM, Mellick GD, Mutez E, Nilsson C, Opala G, Park SS, Puschmann A, Quattrone A, Sharma M, Silburn PA, Sohn YH, Stefanis L, Tadic V, Theuns J, Tomiyama H, Uitti RJ, Valente EM, van de Loo S, Vassilatis DK, Vilariño-Güell C, White LR, Wirdefeldt K, Wszolek ZK, Wu RM, Farrer MJ; Genetic Epidemiology Of Parkinson's Disease (GEO-PD) Consortium.

Lancet Neurol. 2011 Oct;10(10):898-908. doi: 10.1016/S1474-4422(11)70175-2. Epub 2011 Aug 30. Erratum in: Lancet Neurol. 2011 Oct;10(10):870.

PMID:
21885347
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Genetic studies of the protein kinase AKT1 in Parkinson's disease.

Ran C, Westerlund M, Anvret A, Willows T, Sydow O, Galter D, Belin AC.

Neurosci Lett. 2011 Aug 21;501(1):41-4. doi: 10.1016/j.neulet.2011.06.038. Epub 2011 Jun 29.

PMID:
21741444
[PubMed - indexed for MEDLINE]
16.

Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2.

Ramonet D, Daher JP, Lin BM, Stafa K, Kim J, Banerjee R, Westerlund M, Pletnikova O, Glauser L, Yang L, Liu Y, Swing DA, Beal MF, Troncoso JC, McCaffery JM, Jenkins NA, Copeland NG, Galter D, Thomas B, Lee MK, Dawson TM, Dawson VL, Moore DJ.

PLoS One. 2011 Apr 6;6(4):e18568. doi: 10.1371/journal.pone.0018568.

PMID:
21494637
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Impaired nigrostriatal function precedes behavioral deficits in a genetic mitochondrial model of Parkinson's disease.

Good CH, Hoffman AF, Hoffer BJ, Chefer VI, Shippenberg TS, Bäckman CM, Larsson NG, Olson L, Gellhaar S, Galter D, Lupica CR.

FASEB J. 2011 Apr;25(4):1333-44. doi: 10.1096/fj.10-173625. Epub 2011 Jan 13.

PMID:
21233488
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Altered enzymatic activity and allele frequency of OMI/HTRA2 in Alzheimer's disease.

Westerlund M, Behbahani H, Gellhaar S, Forsell C, Belin AC, Anvret A, Zettergren A, Nissbrandt H, Lind C, Sydow O, Graff C, Olson L, Ankarcrona M, Galter D.

FASEB J. 2011 Apr;25(4):1345-52. doi: 10.1096/fj.10-163402. Epub 2010 Dec 16.

PMID:
21163861
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Modeling Parkinson's disease genetics: altered function of the dopamine system in Adh4 knockout mice.

Belin AC, Westerlund M, Anvret A, Lindqvist E, Pernold K, Ogren SO, Duester G, Galter D.

Behav Brain Res. 2011 Mar 1;217(2):439-45. doi: 10.1016/j.bbr.2010.11.023. Epub 2010 Nov 12.

PMID:
21075145
[PubMed - indexed for MEDLINE]
20.

Possible involvement of a mitochondrial translation initiation factor 3 variant causing decreased mRNA levels in Parkinson's disease.

Anvret A, Ran C, Westerlund M, Thelander AC, Sydow O, Lind C, Håkansson A, Nissbrandt H, Galter D, Belin AC.

Parkinsons Dis. 2010 Jun 14;2010:491751. doi: 10.4061/2010/491751.

PMID:
20976088
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk